SurgOnc Today®

On this episode of SurgOnc Today, Dr. Amanda Kirane and Dr. Allison Betof discuss the clinical application of TIL therapy for melanoma patients, including the comprehensive care and teamwork required. They also discuss lessons learned and newer clinical trials optimizing the therapy.

In this episode of SurgOnc Today, we explore the evolving role of value-based care in surgical oncology. Drs. Casey Allen, Matthew Katz, and Cristina O'Donoghue join the discussion to define what "value" truly means in cancer care, examine the evidence behind programs such as ERAS and prehabilitation, and review emerging frameworks used to assess value in oncology. The conversation also addresses stakeholder collaboration and the critical intersection between value-based care and health equity. This episode offers practical insights for surgical oncologists seeking to deliver high-quality, patient-centered, and sustainable cancer care.

In this episode of SurgOnc Today, Drs. Kelly Hewitt and Austin Williams review key breast cancer presentations from the 2026 Society of Surgical Oncology Annual Meeting.

They discuss real-world implementation of SOUND and INSEMA, evolving approaches to axillary management in the neoadjuvant setting, and emerging data on omission of axillary surgery. Additional highlights include outcomes with partial breast irradiation in the setting of variable endocrine therapy adherence and contemporary management of rare breast malignancies such as angiosarcoma.

Together, they explore how these findings are shaping multidisciplinary decision-making and the continued evolution of surgical de-escalation in breast cancer care.

On this episode of SurgOnc Today, Dr. Mihir M. Shah interviews Drs. Shailesh Shrikhande and Syed Ahmad about the barriers that slow clinical trial activation and the steps needed to move innovative ideas into practice more efficiently.

In this new episode of Speaking of SurgOnc, Dr. Rick Greene & Dr. Giorgos Karakousis discuss the article: "Assessing the Evidence for and Utility of Gene Expression Profiling of Primary Cutaneous Melanoma" from the March 2025 issue of the Annals of Surgical Oncology.